High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinomas on Sensitive Areas of the Face: A Report of Clinical Outcomes and Acute and Subacute Toxicities

James M Taylor,Bahar Dasgeb,Spencer Liem,Ayesha Ali,Amy Harrison, Mitchell Finkelstein,Jisun Cha,Rani Anne, Steven Greenbaum, William Sherwin,Wenyin Shi

Advances in radiation oncology(2021)

Cited 5|Views8
No score
Abstract
We demonstrate that HDR-BT can be used as definitive treatment of KCs of the face with excellent cosmetic outcomes and local control. Acute and subacute skin toxicities were most commonly RTOG grade 2 or less with resolution of patient's skin toxicity by 3 months.
More
Translated text
Key words
Basal Cell Carcinoma,Chemoradiotherapy,Photodynamic Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined